Atlanta, GA, United States (4E) – Addiction rehabilitation company BioCorRx, Inc. (OTC: BICX) is opening a new Start Fresh Program (SFP) clinic in Atlanta, Georgia in June.
In an announcement on Friday, BioCorRx said alcohol and drug addiction patients from major cities southeast of Georgia could benefit from the accessibility of the clinic at 5569 Peachtree Dunwoody Rd. Ste. 280. The company’s medical director, Dr. George Fallieras, will oversee the operations of the new clinic.
“Bringing the Start Fresh Program to this highly populated metropolitan area will positively impact many families in the Southeast while creating a broader revenue stream for BioCorRx, Inc.,” BioCorRx CEO Kent Emry said in a press release.
“The Start Fresh brand has gained significant momentum in recent months, and this distribution agreement fits in nicely with our expansion plans across the U.S. Atlanta is a major U.S. hub making it more convenient for people that want access to our program in that heavily populated region of the country,” he added.
The SFP is BioCorRx’s proprietary addiction rehabilitation program and the clinic named after it hopes to curb the increasing number of deaths associated with drunk driving in Georgia. The non-profit group Mother Against Drunk Driving said state deaths from drunk driving increased 11 percent costing the state $1.47 billion annually.
The use of alcohol alone or with drugs accounted for almost one-half of treatment admissions in Atlanta, data from the National Institute on Drug Abuse showed. It also ranks first among drug-related crisis call reasons in Atlanta in 2012, with a total of 21,410 calls that year.
Heroine abuse, meanwhile, accounted for 4.3 percent of treatment admissions, according to the Institute.
Prescription drug abuse indicators revealed that use of oxycodone, a type of opioid, accounted for 3 percent of treatment admissions in 2012. Oxycodone was also reported as the most commonly abused prescription drug in Atlanta.
In the Atlanta-Sandy Springs-Marietta Metropolitan Statistical Area, 8.3 percent or 350,000 persons aged 12 or older were classified as having a substance use disorder in the past year, based on data compiled by the Substance Abuse and Mental Health Services Administration (SAMHSA) from 2005 to 2010. At least 20.9 percent of the same sample also engaged in binge alcohol drinking at least once during the past month, SAMHSA found.
The statistics will help the company capitalize on the promise of its Naltrexone-based time-release implant as well as on unmet demands in the treatment of alcohol and opioid dependence.
BioCorRx have five Start Fresh Program clinics that are currently operating in the US. The company only had one clinic in early 2013.